McKee R H
Exxon Biomedical Sciences, Inc., 1545 Route 22 East, Annandale, New Jersey 08801-0971, USA.
Regul Toxicol Pharmacol. 2000 Aug;32(1):51-5. doi: 10.1006/rtph.2000.1407.
Inhibition of gap junctional intercellular communication (GJIC) has been postulated as a nongenotoxic carcinogenic mechanism, probably related to tumor promotion. Recent studies assessed the role of GJIC in the induction of rodent liver tumors by high levels of phthalate esters. Studies with di(2-ethylhexyl) (DEHP) and diisononyl (DINP) phthalates demonstrated that inhibition of GJIC in rats and mice was well correlated with induction of both liver tumors and markers for peroxisomal proliferation. However, GJIC was unaffected in hamsters and primates, species in which phthalate treatment does not induce peroxisomal proliferation. In vitro studies which extended the database to include human liver cells mirrored the in vivo situation; GJIC was inhibited in rat and mouse cells but not in cells from unresponsive species including humans. Peroxisomal proliferation has been characterized as a species-specific process essential for phthalate-induced rodent liver tumor induction. That GJIC was not inhibited in primate liver or human liver cells provides evidence for a second species-specific carcinogenic process. Thus the GJIC data along with those from studies of peroxisomal proliferation support the view that the carcinogenic effects of DEHP and DINP in rodents are not relevant to humans.
间隙连接细胞间通讯(GJIC)的抑制被假定为一种非遗传毒性致癌机制,可能与肿瘤促进有关。最近的研究评估了GJIC在高剂量邻苯二甲酸酯诱导啮齿动物肝脏肿瘤中的作用。对二(2-乙基己基)邻苯二甲酸酯(DEHP)和二异壬基邻苯二甲酸酯(DINP)的研究表明,大鼠和小鼠中GJIC的抑制与肝脏肿瘤的诱导以及过氧化物酶体增殖标志物均密切相关。然而,在仓鼠和灵长类动物中GJIC未受影响,在这些物种中邻苯二甲酸酯处理不会诱导过氧化物酶体增殖。将数据库扩展至包括人类肝细胞的体外研究反映了体内情况;GJIC在大鼠和小鼠细胞中受到抑制,但在包括人类在内的无反应物种的细胞中未受抑制。过氧化物酶体增殖已被确定为邻苯二甲酸酯诱导啮齿动物肝脏肿瘤所必需的物种特异性过程。灵长类动物肝脏或人类肝细胞中GJIC未受抑制为第二种物种特异性致癌过程提供了证据。因此,GJIC数据以及过氧化物酶体增殖研究的数据支持以下观点:DEHP和DINP对啮齿动物的致癌作用与人类无关。